NCT00947024已完成1 期
The Effect of Food on the Bioavailability of Glipizide
适应症
干预措施
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- Sandoz
- 入组人数
- 18
- 主要终点
- Bioequivalence based on AUC and Cmax
研究概览
简要总结
To demonstrate the effect of food on the bioavailability of Glipizide.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Crossover
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 50 Years（Adult）
- 性别
- Male
- 接受健康志愿者
- 是
入选标准
- •No clinically significant abnormal finding on physical exam, medical history, or clinical laboratory results on screening.
排除标准
- •Positive test results for HIV or hepatitis B or C.
- •Treatment for drug or alcohol dependence.
研究组 & 干预措施
3
Active Comparator
10 mg Glucotrol Tablet (Roerig), Administered Immediately After a Standard Breakfast.
干预措施: 10 mg Glucotrol Tablet (Roerig), Administered Immediately After a Standard Breakfast. (Drug)
1
Experimental
10 mg Glipizide Tablet (Geneva Pharmaceutical, Inc.), Administered Immediately After a Standard Breakfast.
干预措施: 10 mg Glipizide Tablet (Geneva Pharmaceutical, Inc.), Administered Immediately After a Standard Breakfast. (Drug)
2
Experimental
10 mg Glipizide Tablet (Geneva Pharmaceutical, Inc.), Administered After an Overnight Fast.
干预措施: 10 mg Glipizide Tablet (Geneva Pharmaceutical, Inc.), Administered After an Overnight Fast. (Drug)
结局指标
主要结局
Bioequivalence based on AUC and Cmax
时间窗: 15 days
次要结局
未报告次要终点
研究者
相似试验
已完成
1 期
BIOAVAILABILITY OF Glimepiride/Extended Release Metformin (GLI/METXR): High Fat Diet StudyHealthyNCT01437813Laboratorios Silanes S.A. de C.V.24
已完成
1 期
Investigation of the Effect of Food on the Bioavailability of a 25 mg Empagliflozin Tablet as Well as Assessment of Dose Proportionality Between 10 mg and 25 mg Empagliflozin Tablets Under Fasting Conditions.HealthyNCT01451775Boehringer Ingelheim18
已完成
1 期
5 mg Glipizide/500 mg Metformin Hydrochloride Tablets, Non-FastingHealthyNCT00834587Teva Pharmaceuticals USA40
已完成
1 期
5 mg Glipizide/500 mg Metformin Hydrochloride Tablets, FastingHealthyNCT00835497Teva Pharmaceuticals USA40
已完成
1 期
Bioavailability and Pharmacokinetics of BI 10773 Tablet in Healthy Male VolunteersHealthyNCT02172209Boehringer Ingelheim14